Carbidopa, Levodopa And Entacapone
Pricing Report NDC 0378-8300-01

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Carbidopa, Levodopa And Entacapone (NDC 0378-8300-01) is $0.95434 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Oct 17, 2018.

As a provided by Mylan Pharmaceuticals Inc., this medication is distributed in a 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.95434
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Oct 17, 2018
Billable Units
100 EA
Estimated Package Price
$95.43
Data Status
As of Oct 16, 2019
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0378-8300-01
Description
100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since May 2015, the NADAC wholesale price for (NDC ) has moved within a range of $0.95434 to $2.33126 per EA. Over this 3 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.9543 - $2.3313
Market Volatility
144.28% Variance
Latest Trend
50.51%
Date Unit Price Unit Source Method Rate
Oct 17, 2018 $0.95434 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 17, 2018 $0.95434 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Oct 19, 2016 $1.92826 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 19, 2016 $1.92826 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Mar 23, 2016 $2.06582 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 23, 2016 $2.06582 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Nov 18, 2015 $2.33126 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 18, 2015 $2.33126 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Sep 23, 2015 $2.13296 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 23, 2015 $2.13296 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Aug 19, 2015 $1.86704 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2015 $2.26627 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026